Literature DB >> 22442317

Effect of glacial acetic acid treatment of liquid-based cytology collections on performance of Cervista HPV HR for detection of high-risk human papillomavirus.

Erik Munson1, Brian K Du Chateau, Bridget E Nelson, Judith Griep, Jolanta Czarnecka, Robert D Amrhein, Elizabeth R Schroeder.   

Abstract

Inadequate cervical cytological analysis can be facilitated by glacial acetic acid (GAA) treatment of primary liquid-based collections to remove mucus, erythrocytes, inflammatory cells, and cellular debris. In the context of a commercial human papillomavirus (HPV) hybridization assay performed on 465 tandem specimens with and without GAA treatment, we show that GAA treatment significantly reduces genomic DNA content (P < 0.0001) and creates an increased potential for indeterminate and false-negative results. In the context of cytological workflow, laboratories should consider providing a specimen aliquot for HPV DNA detection prior to GAA treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442317      PMCID: PMC3372109          DOI: 10.1128/JCM.06719-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?

Authors:  Joel S Bentz; Leslie R Rowe; Evelyn V Gopez; C Jay Marshall
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

2.  Glacial acetic acid treatment and atypical endocervical glandular cells: an analysis of 92 cases.

Authors:  David Cohen; Julie Shorie; Charles Biscotti
Journal:  Am J Clin Pathol       Date:  2010-05       Impact factor: 2.493

3.  Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.

Authors:  Mark H Einstein; Mark G Martens; Francisco A R Garcia; Daron G Ferris; Amy L Mitchell; Stephen P Day; Marilyn C Olson
Journal:  Gynecol Oncol       Date:  2010-05-21       Impact factor: 5.482

4.  The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid: effect on Hybrid Capture II human papillomavirus testing and clinical follow-up.

Authors:  S Nicholas Agoff; Thomas Dean; Brigette K Nixon; Kathy Ingalls-Severn; Linda Rinker; Verena S Grieco
Journal:  Am J Clin Pathol       Date:  2002-11       Impact factor: 2.493

5.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

6.  Clinical laboratory evaluation of Invader® chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens.

Authors:  Erik Munson; Brian K Du Chateau; Bronya Bellerose; Jolanta Czarnecka; Judy Griep
Journal:  Diagn Microbiol Infect Dis       Date:  2011-09-06       Impact factor: 2.803

7.  A comparison of two methods to determine the presence of high-risk HPV cervical infections.

Authors:  Lawrence R Johnson; Cindi R Starkey; James Palmer; James Taylor; Spencer Stout; Stephanie Holt; Ryan Hendren; Brian Bock; Elizabeth Waibel; Gale Tyree; Gerald C Miller
Journal:  Am J Clin Pathol       Date:  2008-09       Impact factor: 2.493

8.  Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA.

Authors:  C C Ginocchio; D Barth; F Zhang
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

9.  Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay.

Authors:  Anna K Wong; Raymond C-K Chan; W Stephen Nichols; Shikha Bose
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

Review 10.  2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

View more
  3 in total

1.  Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay.

Authors:  Erik Munson; Elizabeth R Schroeder; Kevin C Ross; Connie Yauck; Theresa Bieganski; Robert D Amrhein; Maureen Napierala; April L Harkins
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

2.  Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.

Authors:  Erik Munson; Lynn Kroeger; Sandra Balzer; Robert Amrhein; Kimber L Munson; Maureen Napierala; Richard Hudspeth; Patrick J Dillon
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

3.  Comparative study of a novel application of automated HR HPV assay and stability in a previously untested Preservative media.

Authors:  Mike E Morel; Simon E McBride; Maria P Gomez
Journal:  Papillomavirus Res       Date:  2017-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.